REGN logo

REGN Operating Profit

Annual Operating Profit:

$4.09B-$141.50M(-3.34%)
December 31, 2024

Summary

  • As of today (October 8, 2025), REGN annual operating income is $4.09 billion, with the most recent change of -$141.50 million (-3.34%) on December 31, 2024.
  • During the last 3 years, REGN annual operating profit has fallen by -$4.90 billion (-54.51%).
  • REGN annual operating profit is now -54.51% below its all-time high of $8.99 billion, reached on December 31, 2021.

Performance

REGN Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Quarterly Operating Profit:

$1.08B+$487.80M(+82.44%)
June 30, 2025

Summary

  • As of today (October 8, 2025), REGN quarterly operating income is $1.08 billion, with the most recent change of +$487.80 million (+82.44%) on June 30, 2025.
  • Over the past year, REGN quarterly operating profit has increased by +$9.90 million (+0.93%).
  • REGN quarterly operating profit is now -67.75% below its all-time high of $3.35 billion, reached on June 30, 2021.

Performance

REGN Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

TTM Operating Profit:

$3.84B+$9.90M(+0.26%)
June 30, 2025

Summary

  • As of today (October 8, 2025), REGN TTM operating income is $3.84 billion, with the most recent change of +$9.90 million (+0.26%) on June 30, 2025.
  • Over the past year, REGN TTM operating profit has dropped by -$64.00 million (-1.64%).
  • REGN TTM operating profit is now -57.76% below its all-time high of $9.09 billion, reached on March 31, 2022.

Performance

REGN TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

REGN Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-3.3%+0.9%-1.6%
3Y3 Years-54.5%-2.7%-44.0%
5Y5 Years+85.2%+64.5%+24.5%

REGN Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-54.5%at low-11.8%+82.4%-38.4%+0.3%
5Y5-Year-54.5%+85.2%-67.8%+82.4%-57.8%+24.5%
All-TimeAll-Time-54.5%+2094.4%-67.8%+1889.7%-57.8%+1972.2%

REGN Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.08B(+82.4%)
$3.84B(+0.3%)
Mar 2025
-
$591.70M(-40.2%)
$3.83B(-4.0%)
Dec 2024
$4.09B(-3.3%)
$990.20M(-16.0%)
$3.99B(+0.4%)
Sep 2024
-
$1.18B(+10.3%)
$3.97B(+1.8%)
Jun 2024
-
$1.07B(+42.3%)
$3.90B(+1.4%)
Mar 2024
-
$751.40M(-22.8%)
$3.85B(-4.8%)
Dec 2023
$4.23B(-15.2%)
$972.90M(-12.4%)
$4.05B(-4.1%)
Sep 2023
-
$1.11B(+9.3%)
$4.22B(-2.6%)
Jun 2023
-
$1.02B(+7.4%)
$4.33B(-2.1%)
Mar 2023
-
$946.70M(-17.4%)
$4.43B(-6.6%)
Dec 2022
$4.99B(-44.5%)
$1.15B(-6.3%)
$4.74B(-24.0%)
Sep 2022
-
$1.22B(+10.3%)
$6.23B(-9.1%)
Jun 2022
-
$1.11B(-11.8%)
$6.86B(-24.6%)
Mar 2022
-
$1.26B(-52.3%)
$9.09B(+1.6%)
Dec 2021
$8.99B(+151.5%)
$2.64B(+42.9%)
$8.95B(+19.7%)
Sep 2021
-
$1.85B(-44.8%)
$7.47B(+11.9%)
Jun 2021
-
$3.35B(+200.8%)
$6.68B(+67.5%)
Mar 2021
-
$1.11B(-4.7%)
$3.99B(+11.5%)
Dec 2020
$3.58B(+61.9%)
$1.17B(+10.8%)
$3.58B(+15.9%)
Sep 2020
-
$1.05B(+60.4%)
$3.09B(+11.4%)
Jun 2020
-
$656.40M(-6.2%)
$2.77B(+14.0%)
Mar 2020
-
$700.10M(+3.6%)
$2.43B(+10.0%)
Dec 2019
$2.21B(-12.8%)
$675.70M(-8.5%)
$2.21B(-1.9%)
Sep 2019
-
$738.50M(+134.0%)
$2.25B(+5.2%)
Jun 2019
-
$315.60M(-34.3%)
$2.14B(-12.5%)
Mar 2019
-
$480.00M(-33.2%)
$2.45B(-3.4%)
Dec 2018
$2.53B(+21.9%)
$718.10M(+14.5%)
$2.53B(+7.6%)
Sep 2018
-
$626.90M(+0.8%)
$2.36B(+2.9%)
Jun 2018
-
$622.20M(+9.7%)
$2.29B(+3.2%)
Mar 2018
-
$567.20M(+5.3%)
$2.22B(+6.6%)
Dec 2017
$2.08B(+56.3%)
$538.82M(-3.8%)
$2.08B(+10.2%)
Sep 2017
-
$559.93M(+1.7%)
$1.89B(+11.7%)
Jun 2017
-
$550.31M(+27.8%)
$1.69B(+18.1%)
Mar 2017
-
$430.54M(+24.1%)
$1.43B(+7.6%)
Dec 2016
$1.33B(+6.3%)
$346.96M(-4.4%)
$1.33B(+9.5%)
Sep 2016
-
$362.80M(+24.4%)
$1.21B(-2.4%)
Jun 2016
-
$291.63M(-11.4%)
$1.24B(-4.1%)
Mar 2016
-
$329.31M(+42.5%)
$1.30B(+3.7%)
Dec 2015
$1.25B(+51.9%)
$231.08M(-41.1%)
$1.25B(+1.2%)
Sep 2015
-
$392.42M(+13.8%)
$1.24B(+19.8%)
Jun 2015
-
$344.86M(+21.6%)
$1.03B(+12.7%)
Mar 2015
-
$283.55M(+31.4%)
$915.91M(+11.2%)
Dec 2014
$823.92M(+10.9%)
$215.80M(+14.5%)
$823.92M(+2.6%)
Sep 2014
-
$188.46M(-17.4%)
$803.21M(-5.7%)
Jun 2014
-
$228.09M(+19.1%)
$851.55M(+9.0%)
Mar 2014
-
$191.56M(-1.8%)
$781.56M(+5.2%)
Dec 2013
$743.05M(+62.3%)
$195.09M(-17.6%)
$743.05M(+7.1%)
Sep 2013
-
$236.80M(+49.8%)
$693.63M(+5.2%)
Jun 2013
-
$158.10M(+3.3%)
$659.19M(+12.0%)
Mar 2013
-
$153.05M(+5.1%)
$588.56M(+28.6%)
Dec 2012
$457.71M(+323.1%)
$145.67M(-28.0%)
$457.71M(+71.7%)
Sep 2012
-
$202.36M(+131.3%)
$266.64M(+4481.5%)
Jun 2012
-
$87.48M(+294.0%)
$5.82M(+104.1%)
Mar 2012
-
$22.20M(+148.9%)
-$141.98M(+30.8%)
Dec 2011
-$205.16M(-110.5%)
-$45.40M(+22.3%)
-$205.16M(-18.9%)
Sep 2011
-
-$58.46M(+3.1%)
-$172.53M(-18.0%)
Jun 2011
-
-$60.32M(-47.2%)
-$146.17M(-33.4%)
Mar 2011
-
-$40.98M(-220.7%)
-$109.58M(-12.4%)
Dec 2010
-$97.47M(-31.5%)
-$12.78M(+60.2%)
-$97.47M(+21.5%)
Sep 2010
-
-$32.09M(-35.3%)
-$124.10M(-33.0%)
Jun 2010
-
-$23.72M(+17.8%)
-$93.30M(-8.7%)
Mar 2010
-
-$28.88M(+26.7%)
-$85.84M(-15.8%)
Dec 2009
-$74.10M(+14.1%)
-$39.41M(-2952.5%)
-$74.10M(-12.8%)
Sep 2009
-
-$1.29M(+92.1%)
-$65.71M(+22.1%)
Jun 2009
-
-$16.27M(+5.1%)
-$84.35M(+3.8%)
Mar 2009
-
-$17.14M(+44.7%)
-$87.71M(-1.4%)
Dec 2008
-$86.25M(+24.6%)
-$31.02M(-55.6%)
-$86.48M(-29.1%)
Sep 2008
-
-$19.93M(-1.6%)
-$67.00M(+21.9%)
Jun 2008
-
-$19.62M(-23.3%)
-$85.73M(+11.4%)
Mar 2008
-
-$15.91M(-37.9%)
-$96.72M(+15.5%)
Dec 2007
-$114.45M
-$11.53M(+70.2%)
-$114.45M(+16.1%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$38.67M(-26.3%)
-$136.41M(-8.3%)
Jun 2007
-
-$30.60M(+9.0%)
-$126.00M(-5.3%)
Mar 2007
-
-$33.65M(-0.5%)
-$119.64M(-11.1%)
Dec 2006
-$107.66M(-186.5%)
-$33.49M(-18.5%)
-$107.66M(-174.2%)
Sep 2006
-
-$28.26M(-16.5%)
$145.15M(+4.4%)
Jun 2006
-
-$24.25M(-11.9%)
$139.02M(+6.0%)
Mar 2006
-
-$21.66M(-109.9%)
$131.10M(+5.4%)
Dec 2005
$124.42M(+2103.7%)
$219.31M(+737.8%)
$124.42M(+236.8%)
Sep 2005
-
-$34.39M(-6.9%)
-$90.92M(-37.7%)
Jun 2005
-
-$32.17M(-13.5%)
-$66.01M(-42.0%)
Mar 2005
-
-$28.34M(-813.1%)
-$46.49M(-923.4%)
Dec 2004
$5.65M(+105.6%)
$3.97M(+141.9%)
$5.65M(+136.5%)
Sep 2004
-
-$9.48M(+25.0%)
-$15.47M(+51.2%)
Jun 2004
-
-$12.64M(-153.1%)
-$31.69M(+33.4%)
Mar 2004
-
$23.79M(+238.8%)
-$47.60M(+52.3%)
Dec 2003
-$99.99M(+18.0%)
-$17.14M(+33.3%)
-$99.78M(+14.9%)
Sep 2003
-
-$25.70M(+10.0%)
-$117.27M(+5.2%)
Jun 2003
-
-$28.56M(-0.6%)
-$123.74M(+1.1%)
Mar 2003
-
-$28.38M(+18.1%)
-$125.14M(-2.6%)
Dec 2002
-$121.95M(-42.3%)
-$34.63M(-7.6%)
-$121.95M(-4.3%)
Sep 2002
-
-$32.18M(-7.4%)
-$116.91M(-8.2%)
Jun 2002
-
-$29.95M(-18.9%)
-$108.03M(-12.3%)
Mar 2002
-
-$25.19M(+14.9%)
-$96.17M(-12.2%)
Dec 2001
-$85.68M(-239.0%)
-$29.59M(-27.0%)
-$85.68M(-30.1%)
Sep 2001
-
-$23.29M(-28.8%)
-$65.88M(-13.4%)
Jun 2001
-
-$18.09M(-22.9%)
-$58.07M(-32.4%)
Mar 2001
-
-$14.71M(-50.3%)
-$43.87M(-16.6%)
Dec 2000
-$25.28M(-6.2%)
-$9.79M(+36.8%)
-$37.64M(-31.8%)
Sep 2000
-
-$15.49M(-298.9%)
-$28.55M(-57.2%)
Jun 2000
-
-$3.88M(+54.2%)
-$18.16M(+19.9%)
Mar 2000
-
-$8.48M(-1111.4%)
-$22.68M(+7.8%)
Dec 1999
-$23.80M(-90.4%)
-$700.00K(+86.3%)
-$24.60M(+17.7%)
Sep 1999
-
-$5.10M(+39.3%)
-$29.90M(-9.9%)
Jun 1999
-
-$8.40M(+19.2%)
-$27.20M(-50.3%)
Mar 1999
-
-$10.40M(-73.3%)
-$18.10M(-43.7%)
Dec 1998
-$12.50M(+8.8%)
-$6.00M(-150.0%)
-$12.60M(-8.6%)
Sep 1998
-
-$2.40M(-442.9%)
-$11.60M(-12.6%)
Jun 1998
-
$700.00K(+114.3%)
-$10.30M(+29.9%)
Mar 1998
-
-$4.90M(+2.0%)
-$14.70M(-5.8%)
Dec 1997
-$13.70M(+20.8%)
-$5.00M(-354.5%)
-$13.90M(-3.7%)
Sep 1997
-
-$1.10M(+70.3%)
-$13.40M(+19.8%)
Jun 1997
-
-$3.70M(+9.8%)
-$16.70M(0.0%)
Mar 1997
-
-$4.10M(+8.9%)
-$16.70M(+3.5%)
Dec 1996
-$17.30M(-127.6%)
-$4.50M(-2.3%)
-$17.30M(-11.6%)
Sep 1996
-
-$4.40M(-18.9%)
-$15.50M(-14.8%)
Jun 1996
-
-$3.70M(+21.3%)
-$13.50M(-21.6%)
Mar 1996
-
-$4.70M(-74.1%)
-$11.10M(-30.6%)
Dec 1995
-$7.60M(+74.0%)
-$2.70M(-12.5%)
-$8.50M(+22.0%)
Sep 1995
-
-$2.40M(-84.6%)
-$10.90M(+10.7%)
Jun 1995
-
-$1.30M(+38.1%)
-$12.20M(+41.6%)
Mar 1995
-
-$2.10M(+58.8%)
-$20.90M(+28.4%)
Dec 1994
-$29.20M(+24.7%)
-$5.10M(-37.8%)
-$29.20M(+17.3%)
Sep 1994
-
-$3.70M(+63.0%)
-$35.30M(+13.7%)
Jun 1994
-
-$10.00M(+3.8%)
-$40.90M(-0.5%)
Mar 1994
-
-$10.40M(+7.1%)
-$40.70M(-3.0%)
Dec 1993
-$38.80M(-112.0%)
-$11.20M(-20.4%)
-$39.50M(-14.8%)
Sep 1993
-
-$9.30M(+5.1%)
-$34.40M(-12.1%)
Jun 1993
-
-$9.80M(-6.5%)
-$30.70M(-25.8%)
Mar 1993
-
-$9.20M(-50.8%)
-$24.40M(-32.6%)
Dec 1992
-$18.30M(-90.6%)
-$6.10M(-8.9%)
-$18.40M(-15.0%)
Sep 1992
-
-$5.60M(-60.0%)
-$16.00M(-24.0%)
Jun 1992
-
-$3.50M(-9.4%)
-$12.90M(-13.2%)
Mar 1992
-
-$3.20M(+13.5%)
-$11.40M(-83.9%)
Dec 1991
-$9.60M(-190.9%)
-$3.70M(-48.0%)
-$6.20M(+34.7%)
Sep 1991
-
-$2.50M(-25.0%)
-$9.50M(-66.7%)
Jun 1991
-
-$2.00M(-200.0%)
-$5.70M(-128.0%)
Mar 1991
-
$2.00M(+128.6%)
-$2.50M(+24.2%)
Dec 1990
-$3.30M
-$7.00M(-638.5%)
-$3.30M(-189.2%)
Sep 1990
-
$1.30M(+8.3%)
$3.70M(+54.2%)
Jun 1990
-
$1.20M(0.0%)
$2.40M(+100.0%)
Mar 1990
-
$1.20M
$1.20M

FAQ

  • What is Regeneron Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Regeneron Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Regeneron Pharmaceuticals, Inc.?
  • What is Regeneron Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Regeneron Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of REGN is $4.09B

What is the all-time high annual operating profit for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high annual operating income is $8.99B

What is Regeneron Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, REGN annual operating income has changed by -$141.50M (-3.34%)

What is Regeneron Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of REGN is $1.08B

What is the all-time high quarterly operating profit for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high quarterly operating income is $3.35B

What is Regeneron Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, REGN quarterly operating income has changed by +$9.90M (+0.93%)

What is Regeneron Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of REGN is $3.84B

What is the all-time high TTM operating profit for Regeneron Pharmaceuticals, Inc.?

Regeneron Pharmaceuticals, Inc. all-time high TTM operating income is $9.09B

What is Regeneron Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, REGN TTM operating income has changed by -$64.00M (-1.64%)
On this page